Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2017 Mar 7

PMID 28261087

Citations 15

Authors

Pekka T Mannisto

J Arturo Garcia-Horsman

Affiliations

Soon will be listed here.

Abstract

In the aging brain, the correct balance of neural transmission and its regulation is of particular significance, and neuropeptides have a significant role. Prolyl oligopeptidase (PREP) is a protein highly expressed in brain, and evidence indicates that it is related to aging and in neurodegenration. Although PREP is regarded as a peptidase, the physiological substrates in the brain have not been defined, and after intense research, the molecular mechanisms where this protein is involved have not been defined. We propose that PREP functions as a regulator of other proteins though peptide gated direct interaction. We speculate that, at least in some processes where PREP has shown to be relevant, the peptidase activity is only a consequence of the interactions, and not the main physiological activity.

Citing Articles

Bioactive Properties of Enzymatic Gelatin Hydrolysates Based on In Silico, In Vitro, and In Vivo Studies.

Panjaitan F, Shie S, Park S, Sevi T, Ko W, Aluko R Molecules. 2024; 29(18).

PMID: 39339395 PMC: 11434199. DOI: 10.3390/molecules29184402.

Missense variants in CMS22 patients reveal that PREPL has both enzymatic and nonenzymatic functions.

Monnens Y, Theodoropoulou A, Rosier K, Bhalla K, Mahy A, Vanhoutte R JCI Insight. 2024; 9(17).

PMID: 39078710 PMC: 11385081. DOI: 10.1172/jci.insight.179276.

The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation.

Yu M, Shen Z, Zhang S, Zhang Y, Zhao H, Zhang L Heliyon. 2024; 10(13):e33761.

PMID: 39027618 PMC: 11255520. DOI: 10.1016/j.heliyon.2024.e33761.

Diversification of phenolic glucosides by two UDP-glucosyltransferases featuring complementary regioselectivity.

Guo F, Zhang X, You C, Zhang C, Li F, Li N Microb Cell Fact. 2022; 21(1):208.

PMID: 36217200 PMC: 9549646. DOI: 10.1186/s12934-022-01935-w.

Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications.

Baharin A, Ting T, Goh H Plants (Basel). 2022; 11(10).

PMID: 35631755 PMC: 9147577. DOI: 10.3390/plants11101330.

References

Szeltner Z, Rea D, Juhasz T, Renner V, Mucsi Z, Orosz G . Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase. J Biol Chem. 2002; 277(47):44597-605. DOI: 10.1074/jbc.M207386200. View

Lopez A, Herranz-Trillo F, Kotev M, Gairi M, Guallar V, Bernado P . Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics. Chembiochem. 2016; 17(10):913-7. DOI: 10.1002/cbic.201600102. View

Rampon C, Jiang C, Dong H, Tang Y, Lockhart D, Schultz P . Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci U S A. 2000; 97(23):12880-4. PMC: 18858. DOI: 10.1073/pnas.97.23.12880. View

Julku U, Panhelainen A, Tiilikainen S, Svarcbahs R, Tammimaki A, Piepponen T . Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse. Mol Neurobiol. 2016; 55(1):470-482. DOI: 10.1007/s12035-016-0339-8. View

Tenorio-Laranga J, Luz Valero M, Mannisto P, Sanchez Del Pino M, Garcia-Horsman J . Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain. Anal Biochem. 2009; 393(1):80-7. DOI: 10.1016/j.ab.2009.06.019. View

Chen C, Chan N, Wang A . The many blades of the β-propeller proteins: conserved but versatile. Trends Biochem Sci. 2011; 36(10):553-61. DOI: 10.1016/j.tibs.2011.07.004. View

Fuxreiter M, Magyar C, Juhasz T, Szeltner Z, Polgar L, Simon I . Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways. Proteins. 2005; 60(3):504-12. DOI: 10.1002/prot.20508. View

Szeltner Z, Polgar L . Structure, function and biological relevance of prolyl oligopeptidase. Curr Protein Pept Sci. 2008; 9(1):96-107. DOI: 10.2174/138920308783565723. View

Moreno-Baylach M, Puttonen K, Tenorio-Laranga J, Venalainen J, Storvik M, Forsberg M . Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells. Neurosignals. 2011; 19(2):97-109. DOI: 10.1159/000326342. View

10.

Jalkanen A, Puttonen K, Venalainen J, Sinerva V, Mannila A, Ruotsalainen S . Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats. Basic Clin Pharmacol Toxicol. 2007; 100(2):132-8. DOI: 10.1111/j.1742-7843.2006.00021.x. View

11.

Rossner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth H . Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease. Neurochem Res. 2005; 30(6-7):695-702. DOI: 10.1007/s11064-005-6863-y. View

12.

Garcia-Horsman J, Mannisto P, Venalainen J . On the role of prolyl oligopeptidase in health and disease. Neuropeptides. 2007; 41(1):1-24. DOI: 10.1016/j.npep.2006.10.004. View

13.

Szeltner Z, Renner V, Polgar L . The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain. J Biol Chem. 2000; 275(20):15000-5. DOI: 10.1074/jbc.M000942200. View

14.

Lone A, Nolte W, Tinoco A, Saghatelian A . Peptidomics of the prolyl peptidases. AAPS J. 2010; 12(4):483-91. PMC: 2976987. DOI: 10.1208/s12248-010-9208-y. View

15.

Saidi M, Kamali S, Beaudry F . Characterization of Substance P processing in mouse spinal cord S9 fractions using high-resolution Quadrupole-Orbitrap mass spectrometry. Neuropeptides. 2016; 59:47-55. DOI: 10.1016/j.npep.2016.06.002. View

16.

Brandt I, Scharpe S, Lambeir A . Suggested functions for prolyl oligopeptidase: a puzzling paradox. Clin Chim Acta. 2006; 377(1-2):50-61. DOI: 10.1016/j.cca.2006.09.001. View

17.

Rawlings N, Barrett A, Finn R . Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2015; 44(D1):D343-50. PMC: 4702814. DOI: 10.1093/nar/gkv1118. View

18.

Hannula M, Mannisto P, Myohanen T . Sequential expression, activity and nuclear localization of prolyl oligopeptidase protein in the developing rat brain. Dev Neurosci. 2010; 33(1):38-47. DOI: 10.1159/000322082. View

19.

Bar J, Rahfeld J, Schulz I, Gans K, Ruiz-Carrillo D, Manhart S . Prolyl endopeptidase cleaves the apoptosis rescue peptide humanin and exhibits an unknown post-cysteine cleavage specificity. Adv Exp Med Biol. 2006; 575:103-8. DOI: 10.1007/0-387-32824-6_11. View

20.

Salers P . Evidence for the presence of prolyl oligopeptidase and its endogenous inhibitor in neonatal rat pancreatic beta-cells. Regul Pept. 1994; 50(3):235-45. DOI: 10.1016/0167-0115(94)90004-3. View